III 119th CONGRESS 1st Session S. RES. 436 IN THE SENATE OF THE UNITED STATES October 6, 2025 Mr. Crapo (for himself, Mr. Booker , Mr. Risch , and Mr. Van Hollen ) submitted the following resolution; which was considered and agreed to RESOLUTION Expressing support for the designation of September 2025 as National Prostate Cancer Awareness Month .

Whereas more than 3,300,000 men are living with prostate cancer in the United States; Whereas 1 in 8 men in the United States will be diagnosed with prostate cancer in their lifetimes and 1 in 41 men in the United States will die from prostate cancer; Whereas prostate cancer is the most commonly diagnosed non-skin cancer and the second-leading cause of cancer-related deaths among men in the United States; Whereas the American Cancer Society estimates that, in 2025, 313,780 men will be diagnosed with, and more than 35,770 men will die of, prostate cancer; Whereas 35 percent of newly diagnosed prostate cancer cases occur in men under the age of 65; Whereas the odds of developing prostate cancer rise rapidly after age 50; Whereas having a father or brother with prostate cancer more than doubles the risk of a man developing prostate cancer, with a higher risk for men who have a brother with the disease and the highest risk for men with several affected relatives; Whereas screening by a digital rectal examination and a prostate-specific antigen blood test may be able to detect the disease at an early stage; Whereas, when diagnosed with localized- or regional-stage prostate cancer, the survival rate nears 100 percent; Whereas only 37 percent of men survive more than 5 years if diagnosed with prostate cancer after the cancer has metastasized; Whereas there are typically no noticeable symptoms of prostate cancer in the early stages, making discussions with a doctor regarding appropriate screening critical; Whereas, in fiscal year 2025, Congress appropriated $48,551,000,000 to the National Institutes of Health, including $7,220,000,000 for the National Cancer Institute; Whereas, in fiscal year 2025, Congress appropriated $75,000,000 for the Prostate Cancer Research Program of the Department of Defense; Whereas the Department of Veterans Affairs has established 21 Precision Oncology Centers of Excellence in order to deliver precision oncology services to veterans suffering from prostate cancer; Whereas ongoing research promises further improvements in prostate cancer prevention, early detection, and treatment; and Whereas educating individuals in the United States, including health care providers, about prostate cancer and early detection strategies while emphasizing the importance of consultation with a physician regarding the benefits and risks of screening is essential to saving lives and preserving and protecting families: Now, therefore, be it

That the Senate— (1) expresses support for the designation of National Prostate Cancer Awareness Month ; (2) declares that steps should be taken— (A) to raise awareness about the importance of screening methods for, and treatment of, prostate cancer; (B) to encourage research— (i) to improve screening and treatment for prostate cancer; (ii) to discover the causes of prostate cancer; and (iii) to develop a cure for prostate cancer; and (C) to continue to consider ways to improve access to, and the quality of, health care services for detecting and treating prostate cancer; and (3) calls on the people of the United States, interest groups, and affected persons— (A) to promote awareness of prostate cancer; (B) to take an active role in the fight to end the devastating effects of prostate cancer on individuals, families, and the economy; and (C) to observe National Prostate Cancer Awareness Month with appropriate ceremonies and activities.